Throughout June, the FDA approved drugs for the treatment of diseases including myelodysplastic syndrome, thyroid cancer, endometrial cancer, colorectal cancer, and follicular lymphoma.
An analysis of FDA-approved drugs for oncology. Drug Discov. Today 2014, 19, 1831-1835. [CrossRef] [PubMed]KINCH M S. An analysis of FDA-approved drugs for oncology[J]. Drug Discov Today,2014,19( 12) :1831-1835.Kinch MS. (2014) An analysis of FDA-approved drugs for oncology. ...
This is the first FDA approval for treatment of newly diagnosed PTCL, the agency noted. The trial on which the approval was based was the first to show improved survival in the frontline setting. SUGGESTED for you The data come from the phase 3 ECHELON-2 clinical trial. The full results w...
Although a the share of newly developed orphan drugs has surged over the past decades, orphan drug development has concentrated on few diseases [36]. FDA-approved drugs exist for merely 5% of the more than 7000 rare diseases [36]. Further, clinical trials with new drugs are currently under ...
For many years now, this has led to the development of personalized medicines [119,120] and routine screening of virtual chemical libraries, searching for those that may match a newly discovered target [121]. Therefore, it is now envisaged that computer-aided design (e.g., in silico ...
Two of the newly approved Pfizer treatments were acquired with the help of the firepower the company gained with its massive sales of COVID vaccine Comirnaty and antiviral Paxlovid. Pfizer’s new ulcerative colitis drug Velsipity came by way of the company’s 2022acquisitionof Aren...
Out of the 55 drugs, 33 (60 %) underwent an accelerated review process and received approval, while 25 (45 %) were specifically approved for the treatment of rare diseases. The purpose of this review is to provide an overview of the clinical uses and production techniques of 29 newly FDA...
Oncology Drugs Approved by the FDA in January 2025 Darlene Dobkowski, MA February 4th 2025 January's FDA oncology approvals offer new treatment options for breast cancer, mantle cell lymphoma, and other malignancies. FDA Approves T-DXd for Previously Treated HER2-Low and -Ultralow Metastatic Brea...
with the goal to take action within 6 months.The drug has also received Orphan Drug designation and Breakthrough Therapy designation in the US. If approved under the current timeframe, spesolimab would become the first FDA-approved treatment for this rare and potentially life-threatening neutrophi...
1. FDA approves quizartinib for newly diagnosed acute myeloid leukemia. News release. July 20, 2023. Accessed July 20, 2023. https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-quizartinib-newly-diagnosed-acute-myeloid-leukemia 2. Erba HP, Monetesinos P, Kim HJ, et al. Qui...